Skip to main content
Neurology® Neuroimmunology & Neuroinflammation logoLink to Neurology® Neuroimmunology & Neuroinflammation
. 2022 Jul 12;9(5):e1177. doi: 10.1212/NXI.0000000000001177

Novel Cell-Based Assay for Alpha-3 Nicotinic Receptor Antibodies Detects Antibodies Exclusively in Autoimmune Autonomic Ganglionopathy

PMCID: PMC9278123  PMID: 35821105

In the Article “Novel Cell-Based Assay for Alpha-3 Nicotinic Receptor Antibodies Detects Antibodies Exclusively in Autoimmune Autonomic Ganglionopathy” by Karagiorgou et al.,1 the affiliation for the fifth author, Raffaello Furlan, should be as follows: “Department of Biomedical Sciences, Humanitas University; IRCCS-Humanitas Research Hospital; Milan, Italy.” The authors regret the error.

Reference

  • 1.Karagiorgou K, Dandoulaki M, Mantegazza R, et al. Novel cell-based assay for alpha-3 nicotinic receptor antibodies detects antibodies exclusively in autoimmune autonomic ganglionopathy. Neurol Neuroimmunol Neuroinflamm. 2022;9(3):e1162. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Neurology® Neuroimmunology & Neuroinflammation are provided here courtesy of American Academy of Neurology

RESOURCES